@weisenthal.bsky.social
Cohost of The Odd Lots Podcast Singer and guitarist in Light Sweet Crude
@repauchincloss.bsky.social
Dad. Marine. Massachusetts Congressman. Build an economy that works like Legos, not Monopoly. My only Bluesky account.
@robcaliff.bsky.social
@benthefidler.bsky.social
Biotech journalist; Senior Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy. #BioSky
@monterosatx.com
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more.
@hartungingo.bsky.social
discovery chemistry nerd @Merckgroup; oncology, immunology, targeted protein degradation, ADCs; soccer, politics, tapas can slip into the feed; my own views
@borowitzreport.bsky.social
Home of Truth Free newsletter subscription: BorowitzReport.com
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | [email protected] | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine [email protected]
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@slavin-fpo.bsky.social
Across culture, technology and science, making a mess or cleaning one up You’re stuck in here with me
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@ashishkjha.bsky.social
Physician, Researcher, Advocate for the notion that an ounce of evidence is worth a pound of opinion. @brownpublichealth.bsky.social My views are solely my own (who else would want them??)
@runningdoc.bsky.social
👉 Dad to 3, husband 👉 Cancer physician 🩺 #MedSky #OncSky 👉 Curious scientist 🧬|drug developer 💊 👉 Chief Medical Officer, Monte Rosa Tx 👉 Ex-MD Anderson 👉 Avid runner 🏃 (road and trail) 👉 Avid skier ⛷️(downhill and backcountry) 👉 Boston|Taos|Prague
@zey.bsky.social
It is said that there may be seeming disorder and yet no real disorder at all
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@pdrworld.bsky.social
Biotech exec, pro drug developer. Amateur everything else: COOKING, ferments, preserving, charcuterie, fishing, gardening, weightlifting, BIRDER, photography, physics, literature, writer, history, DAD
@jackwestmd.bsky.social
Thoracic oncologist, VP of Clin Development at Summit Therapeutics, Fmr author & editor @UpToDate, founder of @cancerGRACE, interests in #DataViz & telemedicine. COI at JackWestMD.com
@dshaywitz.bsky.social
Rangy MD/PhD executive applying AI & digital technologies to biopharma & healthy aging. Player-coach. #Biosky #Medsky Also Timmerman Report, DBMI@HMS, AEI; https://www.astoundinghealthtech.com/
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. [email protected] and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@maverickny.bsky.social
Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
@peterbrannen.bsky.social
Mammal 1st book: https://www.harpercollins.com/products/the-ends-of-the-world-peter-brannen?variant=32121859801122 2nd book (Aug, 2025): https://www.harpercollins.com/products/the-story-of-co2-is-the-story-of-everything-peter-brannen?variant=42382167638050
@pkrugman.bsky.social
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/